ArticleCureus2026
Dissecting Cellulitis of the Scalp: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Bimekizumab for dissecting cellulitis of the scalp.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dissecting cellulitis of the scalp, also commonly referred to as dissecting folliculitis, is a rare, chronic, relapsing, suppurative disease characterized by painful nodules, purulent drainage, burrowing, and interconnecting abscesses. Dissecting cellulitis disproportionately affects Black males in early and mid-adulthood and may result in cicatricial alopecia, scarring disfigurement, and impaired quality of life. This narrative introduces a representative case of dissecting cellulitis in an adult Black male, summarizes the epidemiology, etiology, pathology, and evaluation of the condition, reviews evidence-based best practices for management and interdisciplinary consultation, and highlights racial disparities associated with the disorder. By shedding light on dissecting cellulitis, this case report aims to facilitate early diagnosis, optimal management, and favorable outcomes for this progressive and debilitating condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.